课题基金 / 基金详情

EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY

EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
口腔生物学和病理学中的上皮乙酰胆碱
批准号:
7772334
负责人:
SERGEI A GRANDO
金额:
$36.73万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2013-03-31

项目摘要

项目成果

SERGEI A GRANDO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Funding is requested to support our ongoing studies toward identification of molecular mechanisms mediating effects of acetylcholine (ACh), its pharmacologic congeners and tobacco products on oral keratinocytes (OKC). The continuous cycle of keratinocyte birth and death is a self-sustained process controlled, in part, by the local hormone ACh through the signaling pathways that couple each type of ACh receptors to regulation of a particular cell function. Free cytotransmitter ACh is present in physiologically-relevant concentrations in the epithelium lining the upper digestive tract. OKC express both the ACh synthesizing and degrading enzymes, and both nicotinic and muscarinic classes of ACh receptors. A novel paradigm of cell regulation via nicotinic ACh receptors (nAChRs) has been discovered in studies of the cholinergic proteins termed SLURP (secreted mammalian Ly-6/urokinase plasminogen activator receptor-related protein)-1 and -2. Preliminary results indicate that SLURP-1 and -2 regulate keratinocyte proliferation, apoptosis and differentiation. Most importantly, SLURPs and professional nicotinic antagonists can abolish, in part, the abilities of the nicotine- derived nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) to cause transformation of immortalized OKC. We will test the following working hypotheses: 1) the pathobiologic effect of NNK is mediated predominantly via a7 and/or a9 nAChR(s), and that of NNN-via a3- made nAChR(s); 2) SLURP proteins can prevent nitrosamine-dependent transformation of oral cells both in vivo and in vitro, and abolish tobacco/nicotine-dependent alterations in the keratinocyte cell cycle, growth and differentiation; and 3) SLURP-1 competes mainly with NNK for binding to the homopentameric nAChR(s) and SLURP-2-with NNN at the binding site of heteropentameric nAChR(s), and both SLURPs interfere with the nitrosamine-induced nAChR signaling. The Specific Aims will be to determine: 1) the role of keratinocyte nAChRs in mediating the pathobiologic effects of tobacco nitrosamines; 2) the roles for SLURP-1 and -2 in the physiologic protection of OKC from tobacco toxicity; and 3) the receptor-mediated signaling mechanisms mediating SLURP-1 and -2 actions on OKC. The primary significance of the application lies in its goal to elucidate how nicotinic acetylcholine receptors mediate pathobiologic effects of tobacco-derived nitrosamines and how SLURP can prevent the toxic effects of nitrosamines. Integrating structural and functional information about SLURPs and the epithelial acetylcholine axis will facilitate a better understanding of normal development and function of the epithelium lining the upper digestive tract. Learning the pharmacology of the SLURP vs. nitrosamine action on oral keratinocytes will help develop an effective prevention programs wherein hazardous effects of tobacco products are anticipated, or even abolished, by a pharmacologic ligand of a specific nicotinic acetylcholine receptors acting as an antidote.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
  • 批准号:
    8065942
  • 项目类别:
  • 资助金额:
    $34.08万
  • 财政年份:
    2010
  • 负责人:
    SERGEI A GRANDO
  • 依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
  • 批准号:
    7880444
  • 项目类别:
  • 资助金额:
    $34.43万
  • 财政年份:
    2010
  • 负责人:
    SERGEI A GRANDO
  • 依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
  • 批准号:
    8228055
  • 项目类别:
  • 资助金额:
    $34.08万
  • 财政年份:
    2010
  • 负责人:
    SERGEI A GRANDO
  • 依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
  • 批准号:
    8417010
  • 项目类别:
  • 资助金额:
    $33.4万
  • 财政年份:
    2010
  • 负责人:
    SERGEI A GRANDO
  • 依托单位:
海外基金